The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Gene transfer as a tool to induce therapeutic vascular growth
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., & Asahara, T. (1999) · Nature Medicine · doi:10.1038/7434 · Cited by 2,423
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Self-citationCellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Gene silencing in mammals by small interfering RNAs
McManus, M. T., & Sharp, P. A. (2002) · Nature Reviews Genetics · doi:10.1038/nrg908 · Cited by 1,399
Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,205
Self-citationPark, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.12.1114 · Cited by 1,098
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis
Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., Shah, P. K., Willerson, J. T., Benza, R. L., Berman, D. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000061911.47710.8a · Cited by 1,025
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
Self-citationIsner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., & Symes, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03361-2 · Cited by 989
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Villanueva, F. S., Jankowski, R. J., Klibanov, S., Pina, M. L., Alber, S. M., Watkins, S. C., Brandenburger, G. H., & Wagner, W. R. (1998) · Circulation · doi:10.1161/01.cir.98.1.1 · Cited by 809
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V, Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 803
Self-citationMonocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.
Arras, M., Ito, W. D., Scholz, D., Winkler, B., Schaper, J., & Schaper, W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119877 · Cited by 739
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Cao, R., Bråkenhielm, E., Pawliuk, R., Wariaro, D., Post, M. J., Wahlberg, E., Leboulch, P., & Cao, Y. (2003) · Nature Medicine · doi:10.1038/nm848 · Cited by 721
Barton-Davis, E. R., Shoturma, D. I., Musaro, A., Rosenthal, N., & Sweeney, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15603 · Cited by 700
Rosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Karkkainen, M. J., Ferrell, R. E., Lawrence, E. C., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 650
Self-citationSimons, M., Annex, B. H., Laham, R. J., Kleiman, N., Henry, T., Dauerman, H., Udelson, J. E., Gervino, E. V., Pike, M., Whitehouse, M. J., et al. (2002) · Circulation · doi:10.1161/hc0802.104407 · Cited by 645
Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Hicklin, D. J., Zhu, Z., Bohlen, P., Witte, L., et al. (2002) · Nature Medicine · doi:10.1038/nm740 · Cited by 633
Petrova, T. V., Mäkinen, T., Mäkelä, T. P., Saarela, J., Virtanen, I., Ferrell, R. E., Finegold, D. N., Kerjaschki, D., Ylä‐Herttuala, S., & Alitalo, K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf470 · Cited by 632
Self-citationA model for gene therapy of human hereditary lymphedema
Karkkainen, M. J., Saaristo, A., Jussila, L., Karila, K. A., Lawrence, E. C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221449198 · Cited by 606
Self-citationVirus treatment questioned after gene therapy death
Lehrman, S. (1999) · Nature · doi:10.1038/43977 · Cited by 576 · cited 1×
“In retrospect, the death seems to have been a result of toxicity caused by the adenoviral vector in conjunction with the underlying diseas”
BackgroundHedman, M., Hartikainen, J., Syvänne, M., Stjernvall, J., Hedman, A., Kivelä, A., Vanninen, E., Mussalo, H., Kauppila, E., Simula, S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000070540.80780.92 · Cited by 537
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Grines, C. L., Watkins, M. W., Helmer, G., Penny, W., Brinker, J., Marmur, J. D., West, A., Rade, J. J., Marrott, P., Hammond, H. K., et al. (2002) · Circulation · doi:10.1161/hc1102.105595 · Cited by 519
Lederman, R. J., Mendelsohn, F. O., Anderson, R. D., Saucedo, J. F., Tenaglia, A. N., Hermiller, J. B., Hillegass, W. B., Rocha-Singh, K., Moon, T. E., Whitehouse, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08937-7 · Cited by 511
Giordano, F. J., Ping, P., McKirnan, M. D., Nozaki, S., Demaria, A. N., Dillmann, W. H., Mathieu-Costello, O., & Hammond, H. K. (1996) · Nature Medicine · doi:10.1038/nm0596-534 · Cited by 486
Rockson, S. G. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00727-0 · Cited by 474
Ito, W. D., Arras, M., Winkler, B., Scholz, D., Schaper, J., & Schaper, W. (1997) · Circulation Research · doi:10.1161/01.res.80.6.829 · Cited by 470
Losordo, D. W., Vale, P. R., Hendel, R. C., Milliken, C. E., Fortuin, F. D., Cummings, N., Schatz, R. A., Asahara, T., Isner, J. M., & Kuntz, R. E. (2002) · Circulation · doi:10.1161/01.cir.0000015982.70785.b7 · Cited by 466
Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus: An Expert Panel Summary
Simons, M., Bonow, R. O., Chronos, N. A., Cohen, D. J., Giordano, F. J., Hammond, H. K., Laham, R. J., Li, W., Pike, M., Sellke, F. W., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.e73 · Cited by 459
Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y., & Shibuya, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31273 · Cited by 406
Isner, J. M., Baumgartner, I., Rauh, G., Schainfeld, R., Blair, R., Manor, O., Razvi, S., & Symes, J. F. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70022-9 · Cited by 392
Dor, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1939 · Cited by 390
Ylä-Herttuala, S., & Martin, J. F. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04180-x · Cited by 375
Self-citationMäkinen, K., Manninen, H., Hedman, M., Matsi, P., Mussalo, H., Alhava, E., & Ylä-Herttuala, S. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0638 · Cited by 374
Self-citationSpringer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., & Blau, H. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80154-9 · Cited by 363
Miller, D. L., Ortega, S., Bashayan, O., Basch, R., & Basilico, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2260-2268.2000 · Cited by 328
Seiler, C., Pohl, T., Wustmann, K., Hutter, D., Nicolet, P.-A., Windecker, S., Eberli, F. R., & Meier, B. (2001) · Circulation · doi:10.1161/hc4201.097835 · Cited by 324
Vale, P. R., Losordo, D. W., Milliken, C. E., Maysky, M., Esakof, D. D., Symes, J. F., & Isner, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.9.965 · Cited by 318
Vincent, K. A., Shyu, K.-G., Luo, Y., Magner, M., Tio, R. A., Jiang, C., Goldberg, M. A., Akita, G. Y., Gregory, R. J., & Isner, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.18.2255 · Cited by 317
Reversal of experimental diabetic neuropathy by VEGF gene transfer
Schratzberger, P., Walter, D. H., Rittig, K., Bahlmann, F. H., Pola, R., Curry, C., Silver, M., Krainin, J. G., Weinberg, D. H., Ropper, A. H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12188 · Cited by 310
Vale, P. R., Losordo, D. W., Milliken, C. E., McDonald, M. C., Gravelin, L. M., Curry, C. M., Esakof, D. D., Maysky, M., Symes, J. F., & Isner, J. M. (2001) · Circulation · doi:10.1161/01.cir.103.17.2138 · Cited by 307
Kubo, H., Cao, R., Bräkenhielm, E., Mäkinen, T., Cao, Y., & Alitalo, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062040199 · Cited by 305
Self-citationAAV vectors: is clinical success on the horizon?
Monahan, P. E., & Samulski, R. J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301109 · Cited by 290
Vascular endothelial grouth facter B, a novel growth facter for endothelial cells
Olffson, B. (1996) · Medical Entomology and Zoology · Cited by 279
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
Yoon, Y.-S., Murayama, T., Gravereaux, E., Tkebuchava, T., Silver, M., Curry, C., Wecker, A., Kirchmair, R., Hu, C. S., Kearney, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15830 · Cited by 270
Gene Therapy with Viral Vectors
Kootstra, N. A., & Verma, I. M. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140257 · Cited by 267
Morishita, R., Nakamura, S., Hayashi, S.-I., Taniyama, Y., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Takeshita, S., Matsumoto, K., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1379 · Cited by 267
Nerve Growth Factor Promotes Angiogenesis and Arteriogenesis in Ischemic Hindlimbs
Emanueli, C., Salis, M. B., Pinna, A., Graiani, G., Manni, L., & Madeddu, P. (2002) · Circulation · doi:10.1161/01.cir.0000033971.56802.c5 · Cited by 267
The role of fibroblast growth factors in vascular development
Javerzat, S., Auguste, P., & Bikfalvi, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02394-8 · Cited by 266
Lentiviral vectors: turning a deadly foe into a therapeutic agent
Trono, D. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301105 · Cited by 263
Therapeutic lymphangiogenesis with human recombinant VEGF‐C
Szuba, A., Skobe, M., Karkkainen, M. J., Shin, W. S., Beynet, D. P., Rockson, N. B., Dakhil, N., Spilman, S., Goris, M. L., Strauss, H. W., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0401fje · Cited by 260
Self-citationPersico, M. G. (2001) · Vascular Morphogenesis in the Female Reproductive System · doi:10.1007/978-1-4612-0213-4_16 · Cited by 259
Induction of angiogenesis in a mouse model using engineered transcription factors
Rebar, E. J., Huang, Y., Hickey, R., Nath, A. K., Meoli, D., Nath, S., Chen, B., Xu, L., Liang, Y., Jamieson, A. C., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-795 · Cited by 252
Comerota, A. J., Throm, R. C., Miller, K. A., Henry, T., Chronos, N., Laird, J., Sequeira, R., Kent, C. K., Bacchetta, M., Goldman, C., et al. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.123677 · Cited by 237
Design and production of novel tetravalent bispecific antibodies
Coloma, M. J., & Morrison, S. L. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-159 · Cited by 236
Chae, J. K., Kim, I., Lim, S. T., Chung, M. J., Kim, W. H., Kim, H. G., Ko, J. K., & Koh, G. Y. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2573 · Cited by 231
Fibroblast growth factors and their receptors
Galzie, Z., Kinsella, A. R., & Smith, J. A. (1997) · Biochemistry and Cell Biology · doi:10.1139/bcb-75-6-669 · Cited by 214
Laitinen, M., Hartikainen, J., Hiltunen, M. O., Eranen, J., Kiviniemi, M., Narvanen, O., Makinen, K., Manninen, H., Syvanne, M., Martin, J. F., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050016003 · Cited by 212
Svensson, E. C., Marshall, D. J., Woodard, K., Lin, H., Jiang, F., Chu, L., & Leiden, J. M. (1999) · Circulation · doi:10.1161/01.cir.99.2.201 · Cited by 207
Laitinen, M., Mäkinen, K., Manninen, H., Matsi, P., Kossila, M., Agrawal, R. S., Pakkanen, T., Luoma, J. S., Viita, H., Hartikainen, J., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.10-1481 · Cited by 198
Self-citationRissanen, T. T., Vajanto, I., Hiltunen, M. O., Rutanen, J., Kettunen, M. I., Niemi, M., Leppänen, P., Turunen, M. P., Markkanen, J. E., Arve, K., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62566-7 · Cited by 193
Self-citationShyu, K.-G., Manor, O., Magner, M., Yancopoulos, G. D., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.19.2081 · Cited by 188
Tripathy, S. K., Svensson, E. C., Black, H. B., Goldwasser, E., Margalith, M., Hobart, P. M., & Leiden, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10876 · Cited by 174
Gene Transfer in Regenerating Muscle
Vitadello, M., Schiaffino, M. V., Picard, A., Scarpa, M., & Schiaffino, S. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.1-11 · Cited by 172
Second Child in French Trial Is Found to Have Leukemia
Marshall, E. (2003) · Science · doi:10.1126/science.299.5605.320 · Cited by 170
Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
Saaristo, A., Veikkola, T., Tammela, T., Enholm, B., Karkkainen, M. J., Pajusola, K., Bueler, H., Ylä-Herttuala, S., & Alitalo, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020587 · Cited by 170
Self-citationFibroblast growth factor receptors (FGFRs) and their roles in limb development
Xu, X., Weinstein, M., Li, C., & Deng, C.-X. (1999) · Cell and Tissue Research · doi:10.1007/s004410051264 · Cited by 159
Del1 Induces Integrin Signaling and Angiogenesis by Ligation of αVβ3
Penta, K., Varner, J. A., Liaw, L., Hidai, C., Schatzman, R., & Quertermous, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11101 · Cited by 153
Assessment of Risks Associated With Cardiovascular Gene Therapy in Human Subjects
Isner, J. M., Vale, P. R., Symes, J. F., & Losordo, D. W. (2001) · Circulation Research · doi:10.1161/hh1701.096259 · Cited by 149
Rissanen, T. T., Markkanen, J. E., Arve, K., Rutanen, J., Kettunen, M. I., Vajanto, I., Jauhiainen, S., Cashion, L. M., Gruchała, M., Närvänen, O., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0377fje · Cited by 148
Self-citationShyu, K., Chang, H., Wang, B.-W., & Kuan, P. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01392-x · Cited by 136
Hiltunen, M., Laitinen, M., Turunen, M. P., Jeltsch, M., Hartikainen, J. E. K., Rissanen, T. T., Laukkanen, J. M., Niemi, M., Kossila, M., Häkkinen, T., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2262 · Cited by 134
Self-citationRegulated gene expression systems
Clackson, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301120 · Cited by 134
Recombinant AAV vector encoding human VEGF165 enhances wound healing
Deodato, B., Arsic, N., Zentilin, L., Galeano, M., Santoro, D., Torre, V., Altavilla, D., Valdembri, D., Bussolino, F., Squadrito, F., et al. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301697 · Cited by 130
Peppe, S. R. D., Mangoni, A., Zambruno, G., Spinetti, G., Melillo, G., Napolitano, M., & Capogrossi, M. C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301798 · Cited by 128
Rajagopalan, S., Shah, M. B., Luciano, A. E., Crystal, R. G., & Nabel, E. G. (2001) · Circulation · doi:10.1161/hc3201.095192 · Cited by 123
FrzA, a Secreted Frizzled Related Protein, Induced Angiogenic Response
Dufourcq, P., Couffinhal, T., Ezan, J., Barandon, L., Moreau, C., Daret, D., & Duplàa, C. (2002) · Circulation · doi:10.1161/01.cir.0000039342.85015.5c · Cited by 115
Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G., & Giacca, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00034-0 · Cited by 108
Koponen, J., Kankkonen, H. M., Kannasto, J., Wirth, T., Hillen, W., Bujard, H., & Ylä‐Herttuala, S. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301889 · Cited by 96
Self-citationFrzA, a Secreted Frizzled Related Protein, Induced Angiogenic Response
PascaleDufourcq, Couffinhal, T., Ezan, J., et al. (2002) · Circulation · Cited by 92
Hiltunen, M., Turunen, M. P., Turunen, A., et al. (2000) · The FASEB Journal · doi:10.1096/fj.00-0145com · Cited by 88
Rissanen, T. T., Vajanto, I., & Ylä‐Herttuala, S. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00864.x · Cited by 84
Self-citationEmanueli, C., Zacheo, A., Minasi, A., Chao, J., Chao, L., Salis, M. B., Stacca, T., Straino, S., Capogrossi, M. C., & Madeddu, P. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2379 · Cited by 81
Novel chimeric gene promoters responsive to hypoxia and ionizing radiation
Greco, O., Marples, B., Dachs, G. U., Williams, K. J., Patterson, A. V., & Scott, S. D. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301823 · Cited by 76
Tissue Repair with a Therapeutic Transcription Factor
Bryant, M., Drew, G. M., Houston, P., Hissey, P., Campbell, C. J., & Braddock, M. (2000) · Human Gene Therapy · doi:10.1089/104303400750001444 · Cited by 74
Stewart, J. M., Munoz, J., & Weldon, A. (2002) · Circulation · doi:10.1161/01.cir.0000040999.00692.f3 · Cited by 71
Mesri, E. A., Federoff, H. J., & Brownlee, M. (1995) · Circulation Research · doi:10.1161/01.res.76.2.161 · Cited by 70
In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo
Wright, M. J., Wightman, L., Latchman, D., et al. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301614 · Cited by 69
Insights into the Molecular Pathogenesis and Targeted Treatment of Lymphedema
Saaristo, A. M., Karkkainen, M. J., & Alitalo, K. K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04871.x · Cited by 64
Self-citationStimulation of Angiogenesis by Cyr61 Gene: A New Therapeutic Candidate
Fataccioli, V., Abergel, V., Wingertsmann, L., Neuville, P., Spitz, E., Adnot, S., Calenda, V., & Teiger, E. (2002) · Human Gene Therapy · doi:10.1089/10430340260185094 · Cited by 58
D’Orazi, G., Marchetti, A., Crescenzi, M., Coen, S., Sacchi, A., & Soddu, S. (2000) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(200001/02)2:1<52::aid-jgm82>3.0.co;2-4 · Cited by 26
Cited by
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191
Wound repair and regeneration: Mechanisms, signaling, and translation
Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.09.024 · Cited by 2,840
Lymphangiogenesis in development and human disease
Alitalo, K., Tammela, T., & Petrova, T. V. (2005) · Nature · doi:10.1038/nature04480 · Cited by 1,285
Self-citationThe biology of vascular endothelial growth factors
TAMMELA, T., ENHOLM, B., ALITALO, K., & PAAVONEN, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.002 · Cited by 838
Self-citation
Metadata
- Authors
- Ylä-Herttuala, S., & Alitalo, K.
- Venue
- Nature Medicine
- Published
- 2003-06
- Volume
- 9
- Issue
- 6
- Pages
- 694-701
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2053706156
- Cited by
- 404
- References
- 103
- FWCI
- 15.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.